The developed aptamer targeting TNF-α (Apt-TNF-α) could eliminate acute lipopolysaccharide (LPS)-induced acute lung injury (ALI) and associated acute liver failure (ALF) in mice (Lai W. Y et al., 2019). Here, TNF is linked to acute liver failure.